What is NDC 70069-804?

70069-804 is the product NDC for Sumatriptan, Sumatriptan succinate 6 mg/.5mL injection, solution, listed with the FDA by Somerset Therapeutics, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sumatriptan?

75 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sumatriptan NDC 70069-804 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70069-804Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70069-0804Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70069-804-01	7006908040170069080401	1 VIAL in 1 CARTON (70069-804-01) / .5 mL in 1 VIALMarketed from Oct 25, 2021
70069-804-05	7006908040570069080405	5 VIAL in 1 CARTON (70069-804-05) / .5 mL in 1 VIALMarketed from Oct 25, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sumatriptan
Generic name (nonproprietary): sumatriptan
Active ingredients: Sumatriptan succinate — 6 mg/.5mL
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: Somerset Therapeutics, LLCNDC labeler code 70069
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213998
Marketing start: Oct 25, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 70069-804_53c62307-bd19-4418-b1b0-c0274b5595dfSPL ID 53c62307-bd19-4418-b1b0-c0274b5595dfSPL set ID 53c62307-bd19-4418-b1b0-c0274b5595dfRxCUI 313165UNII J8BDZ68989UPC 0370069804018
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470069080401 followed by a unit qualifier and the quantity

Package 70069-0804-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 22, 2021.

Indications (excerpt from the label)

Sumatriptan Injection, USP is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache. Limitations of Use: • Use only if a clear diagnosis of migraine or cluster headache has been established. If a patient has no response to the first migraine or cluster headache attack treated with Sumatriptan Injection, reconsider the diagnosis before Sumatriptan Injection is administered to treat any subsequent attacks. • Sumatriptan Injection is not indicated for the prevention of migraine attacks or cluster headache attacks. Sumatriptan injection is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for: • Acute treat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70069-804

What is NDC 70069-804?: 70069-804 is the product NDC for Sumatriptan, Sumatriptan succinate 6 mg/.5mL injection, solution, listed with the FDA by Somerset Therapeutics, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sumatriptan.
What is the active ingredient?: Sumatriptan succinate.
Who is the labeler?: Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sumatriptan?: 75 other product NDCs are listed under this name. See all Sumatriptan NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sumatriptan NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	Armas Pharmaceuticals Inc.	72485-518	72485-0518-05
Sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	Strides Pharma Science Limited	64380-740	64380-0740-0164380-0740-02
sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	ONESOURCE SPECIALTY PHARMA LIMITED	83270-151	83270-0151-07
sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	ONESOURCE SPECIALTY PHARMA LIMITED	83270-152	83270-0152-07
sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	ONESOURCE SPECIALTY PHARMA LIMITED	83270-005	83270-0005-01
sumatriptan	Sumatriptan succinate 25 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-8109	50090-8109-00
sumatriptan	Sumatriptan succinate 25 mg/1	Tablet, Film coatedOral	Rising Pharma Holdings, Inc.	64980-660	64980-0660-2764980-0660-3664980-0660-91
sumatriptan	Sumatriptan succinate 50 mg/1	Tablet, Film coatedOral	Rising Pharma Holdings, Inc.	64980-661	64980-0661-2764980-0661-3664980-0661-91
sumatriptan	Sumatriptan succinate 100 mg/1	Tablet, Film coatedOral	Rising Pharma Holdings, Inc.	64980-662	64980-0662-2764980-0662-3664980-0662-91
Sumatriptan	Sumatriptan succinate 50 mg/1	Tablet, Film coatedOral	Advanced Rx of Tennessee, LLC	80425-0475	80425-0475-01

All 76 Sumatriptan NDCs

Other NDCs under ANDA 213998

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213998
Product	Strength	Form · route	Labeler	Product NDC
Sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	A-S Medication Solutions	50090-7957
Sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	Caplin Steriles Limited	65145-118
Sumatriptansumatriptan succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Xellia Pharmaceuticals USA LLC	70594-068
Sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	Armas Pharmaceuticals Inc.	72485-518